James R Meyers's Net Worth

$11.7 Million

Estimate Recalculated Apr 1, 2025 09:49PM EST

Who is James R Meyers

James R Meyers has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES INC, SANGAMO THERAPEUTICS, INC, Arbutus Biopharma Corp, and CytomX Therapeutics, Inc..

SEC CIK

James R Meyers's CIK is 0001387521

Past Insider Trading and Trends

2017 was James R Meyers's most active year for acquiring shares with 9 total transactions. James R Meyers's most active month to acquire stocks was the month of January. 2007 was James R Meyers's most active year for disposing of shares, totalling 18 transactions. James R Meyers's most active month to dispose stocks was the month of March. 2018 saw James R Meyers paying a total of $2,171,278.80 for 254,138 shares, this is the most they've acquired in one year. In 2018 James R Meyers cashed out on 203,970 shares for a total of $8,157,260.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GILEAD SCIENCES INC

EVP Worldwide Commercial Ops
Updated Feb 23, 2018
Form 4
3.78%
5.00K
$71.52
-$119.12K
Feb 23, 2018
137.48K
Grant
Feb 15 - Feb 21
Form 4
75.49K
Feb 05, 2018
75.49K
Grant
Feb 01
Form 4
-97.36%
-100.00K
$50.91
-$5.87M
Jan 18, 2018
2.72K
Sale
ScheduledJan 16
Form 4
1.01%
1.33K
$73.02
-$100.26K
Nov 13, 2017
132.48K
Grant
Nov 09
Form 4
-1.60%
-2.21K
$73.46
-$162.49K
Nov 07, 2017
135.61K
Options
Nov 05
Form 4
-95.67%
-60.00K
$52.10
-$3.73M
Sep 05, 2017
2.72K
Sale
Aug 31
Form 4
0.09%
115.00
$59.76
$6.87K
Aug 31, 2017
128.86K
Grant
Aug 15
Form 4
-0.21%
-295.00
$72.70
-$21.45K
Aug 14, 2017
137.71K
Options
Aug 10
Form 4
0.27%
343.00
$64.82
-$131.71K
Feb 21, 2017
128.22K
Grant
Feb 15 - Feb 16
Form 4
42.39K
Feb 06, 2017
42.39K
Grant
Feb 02
Form 4
28.04K
Dec 13, 2016
28.04K
Grant
Dec 10
Form 3
Nov 21, 2016
127.88K
Form 4
May 15, 2007
Form 4
-51.94%
-9.00K
$45.29
-$682.00K
Apr 26, 2007
8.33K
Sale
Apr 24
Form 4
-26.38%
-6.00K
$39.78
-$378.82K
Mar 01, 2007
16.74K
Sale
Feb 28
Form 4
63.00K
Jan 24, 2007
63.00K
Grant
Jan 22
Form 3
Jan 24, 2007
Form 3
Jan 24, 2007
1.03K
Showing 18 results

SANGAMO THERAPEUTICS, INC

Investor
Updated Jun 06, 2024
Form 4
151.21%
75.00K
Jun 06, 2024
124.60K
Grant
Jun 04
Form 4
116.67%
41.65K
Jun 05, 2023
77.35K
Grant
Jun 01
Form 4
161.64%
37.50K
Mar 01, 2022
60.70K
Grant
Feb 25
Form 4
164.00%
24.60K
Mar 01, 2021
39.60K
Grant
Feb 25
Form 4/A
600.00%
30.00K
Jun 03, 2020
35.00K
Grant
May 18
Form 4
350.00%
17.50K
May 20, 2020
22.50K
Grant
May 18
Form 4
35.00K
Nov 26, 2019
35.00K
Grant
Nov 22
Form 3
Nov 26, 2019
Showing 8 results

Arbutus Biopharma Corp

Investor
Updated May 24, 2024
Form 4
67.00K
May 24, 2024
67.00K
Grant
May 23
Form 4
55.00K
May 26, 2023
55.00K
Grant
May 24
Form 4
41.00K
May 26, 2022
41.00K
Grant
May 25
Form 4
22.00K
Jun 07, 2021
22.00K
Grant
Jun 03
Form 4
22.00K
Jun 01, 2020
22.00K
Grant
May 28
Form 4
22.00K
Aug 20, 2019
22.00K
Grant
Aug 17
Form 4
44.00K
Oct 22, 2018
44.00K
Grant
Oct 18
Form 3
Oct 22, 2018
Showing 8 results

CytomX Therapeutics, Inc.

Investor
Updated May 17, 2024
Form 4
38.00K
May 17, 2024
38.00K
Grant
May 15
Form 4
25.00K
Jun 16, 2023
25.00K
Grant
Jun 14
Form 4
25.00K
Jun 17, 2022
25.00K
Grant
Jun 15
Form 4
20.00K
Jun 17, 2021
20.00K
Grant
Jun 16
Form 4
20.00K
Jun 19, 2020
20.00K
Grant
Jun 17
Form 4
14.00K
Jun 21, 2019
14.00K
Grant
Jun 19
Form 4
28.00K
Dec 27, 2018
28.00K
Grant
Dec 20
Form 3
Dec 27, 2018
Showing 8 results